Table 2. Demographic and clinical data of AML patients and healthy controls of Jordanian Arab descent included in this study.
| Demographic Data | Cases (n = 30) | Controls (n = 225) |
|---|---|---|
| Gender (%) | ||
| Male | 15 (50) | 78 (34.7) |
| Female | 15 (50) | 147 (65.3) |
| Age (%) | ||
| 0–14 | 1 (3.3) | 5 (2.2) |
| 15–19 | 1 (3.3) | 27 (12) |
| 20–40 | 8 (26.7) | 149 (66.2) |
| 41–55 | 7 (23.3) | 36 (16) |
| >55 | 13 (43.3) | 8 (3.6) |
| Mean (SD) | 48.3 (18.3) | 30.6 (11.8) |
| Clinical Data | ||
| Survival Status | - | |
| Alive | 11 (36.7) | - |
| Dead | 19 (63.3) | - |
| Overall Survival (Months) | - | |
| Median | 11 | - |
| Serum LDH | - | |
| Mean (SD) | 1013.7 (1045.4) | - |
| Total Protein | - | |
| Mean (SD) | 67.7 (14.9) | - |
| Serum Albumin | - | |
| Mean (Range) | 35.9 (8.8) | - |
| Platelets | - | |
| Mean (Range) | 96.4 (122.8) | - |
| Hgb | - | |
| Mean (Range) | 8.6 (2.6) | - |
| WBC | - | |
| Mean (Range) | 37.7 | - |
| Total Monocyte | - | |
| Mean (Range) | 19.1 | - |